Share This

Related Topics News -

     
 Detail   |   Print 
     
復宏漢霖Prolia與Xgeva兩項上市許可申請獲EMA受理
2024-05-24T  
《復牌》復星醫藥考慮中交易可能牽涉附屬復宏漢霖
2024-05-24T  
復宏漢霖開市前停牌 待發內幕消息公告
2024-05-23T  
復宏漢霖漢達遠獲藥監局批准新增四項適應症
2024-05-22T  
復宏漢霖旗下拉索昔芬片臨床試驗申請獲國家藥監局批准
2024-05-14T  
復宏漢霖HLX22獲FDA批准臨床試驗
2024-05-06T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.